HomeLearnInvesting Psychology: A Decision Journal for Avoiding Common Biases

Investing Psychology: A Decision Journal for Avoiding Common Biases

Published on

Better investing psychology starts with a repeatable decision process, not a promise to feel no fear. A written thesis, a contrary-evidence check and a planned review can make it easier to distinguish new information from a reaction to price movement.

The SEC’s investor-behavior bulletin discusses patterns such as excessive trading and decisions made without fundamental information. This article translates that general concern into a practical research routine; the journal below is our original working template, not a validated psychological test.

1. Anchoring: the purchase price becomes the story

An investor buys a stock at $100. It falls to $70, and the only reason offered for keeping it is that it should return to $100. The original transaction price has become the reference point, even though it may have little connection to current business value.

A useful counter-question is: if the position were cash today, would the same evidence justify creating this exposure now? The answer does not automatically determine a trade, because taxes, costs and allocation also matter. It does force the business case to stand apart from the emotional wish to erase a loss.

2. Confirmation bias: research becomes reassurance

Searching only for optimistic commentary after buying a stock can make the thesis feel stronger without adding reliable evidence. A better practice is to record the strongest credible argument against the position and the observable fact that would support it.

For example, if a growth thesis relies on customer renewals, write down how you will judge renewal quality from company disclosures. A critical question is not disloyalty to the company; it is part of owning an uncertain investment.

3. Outcome bias: a winning trade proves the process was good

A favorable return can follow weak reasoning, and a sensible decision can lose money. Judge the process using what was knowable at the time, rather than only the result. Otherwise, lucky outcomes reward habits that may fail when conditions change.

Separate two review columns: decision quality and outcome. The first asks whether sources, valuation, risks and sizing were considered. The second records what happened. Comparing the columns over many decisions is more informative than rewriting a single success into evidence of forecasting skill.

A reusable decision journal

On small screens, swipe horizontally to see all columns.

Field What to record
Date and source cutoff Exactly what information was available before the decision
Thesis One sentence explaining the expected business outcome
Valuation The assumptions required by the current price
Contrary evidence The strongest credible challenge to the thesis
Exposure How the position overlaps with the rest of the portfolio
Invalidation A specific business development that would require reassessment
Review trigger A disclosure, event or chosen review date

A sample thesis might be: recurring sales will grow without weaker cash collection. A sample invalidation might be: several reporting periods show rising receivables without a convincing timing explanation. Neither sentence predicts a precise stock price; both make later evaluation more concrete.

Loss arithmetic can distort intuition

A 20% decline requires a 25% gain to return to the original value. Starting at $100, a fall to $80 is a $20 loss; recovering $20 from an $80 base means 25%. A 50% decline requires a 100% gain. These calculations explain why equal percentage losses and gains do not cancel out.

They do not justify desperate risk-taking to recover quickly. Increasing leverage to reach an old account balance can create a larger downside without improving the quality of the underlying idea.

Reduce avoidable pressure before the next headline

Keep money needed for near-term obligations separate from a thesis that may take years to resolve. Review concentration, including overlapping fund holdings. The Investor.gov risk-tolerance guide connects risk decisions with goals and when money is needed.

Our diversification guide offers a second check. A journal can improve organization, but it cannot compensate for exposure that exceeds the investor’s capacity to absorb loss.

FAQ: Should I ignore every short-term price move?

No. A price move can point to new information or a changed risk. The task is to investigate the cause and compare it with the written thesis, rather than treating every move as either meaningless noise or an instruction to trade immediately.

Educational information, not personalized investment, accounting or tax advice. Examples are hypothetical. Investments can lose value, and neither income nor capital appreciation is guaranteed.

Latest articles

Home Depot Stock Forecast: October 2026

Home Depot’s October 2026 outlook after Q2 results: confirmed guidance, housing-demand signals, Pro strategy, margins and the November earnings setup.

Berkshire Dividend and Share-Class Guide 2026–2027

Berkshire’s retained-earnings dividend policy, BRK.A versus BRK.B rights, conversion arithmetic and the evidence needed for any 2027 payout change.

UNH Stock Forecast October 2026: Q3 Guide

UnitedHealth’s October 2026 stock outlook before Q3 results: official Q2 baseline, updated earnings guidance, medical-cost questions and Optum risks.

Disney Dividend and Stock Split Outlook 2026–2027

Disney’s two $0.75 payments in 2026, a semiannual 2027 income framework and why earnings guidance or stock-split rumors are not dividend declarations.

More like this

Home Depot Stock Forecast: October 2026

Home Depot’s October 2026 outlook after Q2 results: confirmed guidance, housing-demand signals, Pro strategy, margins and the November earnings setup.

Berkshire Dividend and Share-Class Guide 2026–2027

Berkshire’s retained-earnings dividend policy, BRK.A versus BRK.B rights, conversion arithmetic and the evidence needed for any 2027 payout change.

UNH Stock Forecast October 2026: Q3 Guide

UnitedHealth’s October 2026 stock outlook before Q3 results: official Q2 baseline, updated earnings guidance, medical-cost questions and Optum risks.